- TMCI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
Treace Medical Concepts (TMCI) S-8Registration of securities for employees
Filed: 4 Mar 22, 5:30pm
As filed with the Securities and Exchange Commission on March 4, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Treace Medical Concepts, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 47-1052611 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
203 Fort Wade Rd., Suite 150 Ponte Vedra, Florida | 32081 | |
(Address of Principal Executive Offices) | (Zip Code) |
2021 Incentive Award Plan
2021 Employee Stock Purchase Plan
(Full Title of the Plan)
Jaime A. Frias
Chief Legal Officer and Corporate Secretary
Treace Medical Concepts, Inc.
203 Fort Wade Rd., Suite 150
Ponte Vedra, Florida, 32801
(904) 373-5940
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Brian J. Cuneo Phillip S. Stoup Latham & Watkins LLP 140 Scott Drive Menlo Park, California 94025 Telephone: (650) 328-4600 Facsimile: (650) 463-2600 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Proposed sale to take place as soon after the effective date of the
registration statement as awards under the plans are exercised and/or vest.
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 3,250,864 shares of the Registrant’s common stock issuable under the following employee benefit plans for which the Registration Statement of the Registrant on Form S-8 (File No. 333-255541) are effective: (i) the 2021 Incentive Award Plan, as a result of the operation of an automatic annual increase provision therein, which added 2,709,054 shares of common stock, and (ii) the 2021 Employee Stock Purchase Plan, as a result of the operation of an automatic annual increase provision therein, which added 541,810 shares of common stock.
INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION STATEMENT ON FORM S-8
Pursuant to Instruction E of Form S-8, the contents of the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 27, 2021 (File No. 333-255541) is incorporated by reference herein.
Item 8. Exhibits.
EXHIBIT INDEX
Incorporated by Reference | ||||||||||||
Exhibit | Description | Form | Exhibit | Date Filed | Filed Herewith | |||||||
4.1 | Amended and Restated Certificate of Incorporation of Treace Medical Concepts, Inc. | 8-K | 3.1 | 4/27/2021 | ||||||||
4.2 | Amended and Restated Bylaws of the Treace Medical Concepts, Inc. | 8-K | 3.2 | 4/27/2021 | ||||||||
4.3 | Form of Common Stock Certificate | S-1/A | 4.2 | 4/19/2021 | ||||||||
5.1 | Opinion of Latham & Watkins LLP. | X | ||||||||||
23.1 | Consent of Latham & Watkins LLP (included in Exhibit 5.1). | X | ||||||||||
23.2 | Consent of Independent Registered Public Accounting Firm. | X | ||||||||||
24.1 | Power of Attorney (included in the signature page to this registration statement). | X | ||||||||||
99.1# | 2021 Incentive Award Plan and related form agreements | S-8 | 99.2 | 4/27/2021 | ||||||||
99.2# | 2021 Employee Stock Purchase Plan | S-8 | 99.3 | 4/27/2021 | ||||||||
107 | Filing Fee Table. | X |
# | Indicates management contract or compensatory plan. |
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ponte Vedra, State of Florida, on this 4th day of March 2022.
Treace Medical Concepts, Inc. | ||
By: | /s/ John T. Treace | |
John T. Treace | ||
Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints John T. Treace and Mark L. Hair, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Registration Statement, including post-effective amendments or any abbreviated registration statement and any amendments thereto filed, with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
Signature | Title | Date | ||
/s/ John T. Treace John T. Treace | Chief Executive Officer and Director (Principal Executive Officer) | March 4, 2022 | ||
/s/ Mark L. Hair Mark L. Hair | Chief Financial Officer (Principal Financial and Accounting Officer) | March 4, 2022 | ||
/s/ James T. Treace. James T. Treace | Chairman of the Board of Directors | March 4, 2022 | ||
/s/ John K. Bakewell John K. Bakewell | Director | March 4, 2022 | ||
/s/ F. Barry Bays F. Barry Bays | Director | March 4, 2022 | ||
/s/ Lawrence W. Hamilton Lawrence W. Hamilton | Director | March 4, 2022 | ||
/s/ Betsy Hanna Betsy Hanna | Director | March 4, 2022 | ||
/s/ Deepti Jain Deepti Jain | Director | March 4, 2022 |
/s/ Richard W. Mott Richard W. Mott | Director | March 4, 2022 | ||
/s/ Thomas E. Timbie Thomas E. Timbie | Director | March 4, 2022 | ||
/s/ John R. Treace John R. Treace | Director | March 4, 2022 |